Information Provided By: 
Fly News Breaks for September 11, 2018
ENDP
Sep 11, 2018 | 06:09 EDT
Goldman Sachs analyst Dana Flanders upgraded Endo International to Neutral and raised his price target for the shares to $15 from $14. The company is demonstrating "encouraging progress across its business," Flanders tells investors in a research note. He highlights the "strong double-digit " Xiaflex growth and the deals that will bolster Endo's generic injectables. The analyst, however, continues to view the stock's valuation as "stretched."
News For ENDP From the Last 2 Days
There are no results for your query ENDP
